Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer
The tumour microenvironment consists of malignant cells, stroma, and immune cells. Prominent tumour-infiltrating lymphocytes (TILs) in breast cancer are associated with a good prognosis and are predictors of a pathological complete response (pCR) with neoadjuvant chemotherapy (NAC). The contribution...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2016/4757405 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850165665408745472 |
|---|---|
| author | Viriya Kaewkangsadan Chandan Verma Jennifer M. Eremin Gerard Cowley Mohammed Ilyas Oleg Eremin |
| author_facet | Viriya Kaewkangsadan Chandan Verma Jennifer M. Eremin Gerard Cowley Mohammed Ilyas Oleg Eremin |
| author_sort | Viriya Kaewkangsadan |
| collection | DOAJ |
| description | The tumour microenvironment consists of malignant cells, stroma, and immune cells. Prominent tumour-infiltrating lymphocytes (TILs) in breast cancer are associated with a good prognosis and are predictors of a pathological complete response (pCR) with neoadjuvant chemotherapy (NAC). The contribution of different T effector/regulatory cells and cytokines to tumour cell death with NAC requires further characterisation and was investigated in this study. Breast tumours from 33 women with large and locally advanced breast cancers undergoing NAC were immunohistochemically (intratumoural, stromal) assessed for T cell subsets and cytokine expression using labelled antibodies, employing established semiquantitative methods. Prominent levels of TILs and CD4+, CD8+, and CTLA-4+ (stromal) T cells and CD8+ : FOXP3+ ratios were associated with a significant pCR; no association was seen with FOXP3+, CTLA-4+ (intratumoural), and PD-1+ T cells. NAC significantly reduced CD4+, FOXP3+, CTLA-4+ (stromal) (concurrently blood FOXP3+, CTLA-4+ Tregs), and PD-1+ T cells; no reduction was seen with CD8+ and CTLA-4+ (intratumoural) T cells. High post-NAC tumour levels of FOXP3+ T cells, IL-10, and IL-17 were associated with a failed pCR. Our study has characterised further the contribution of T effector/regulatory cells and cytokines to tumour cell death with NAC. |
| format | Article |
| id | doaj-art-ee681fc08f3f433685577163a2e44cfd |
| institution | OA Journals |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-ee681fc08f3f433685577163a2e44cfd2025-08-20T02:21:41ZengWileyJournal of Immunology Research2314-88612314-71562016-01-01201610.1155/2016/47574054757405Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast CancerViriya Kaewkangsadan0Chandan Verma1Jennifer M. Eremin2Gerard Cowley3Mohammed Ilyas4Oleg Eremin5Division of Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, Faculty of Medicine and Health Sciences, University of Nottingham, E Floor, West Block, Queen’s Medical Centre, Derby Rd, Nottingham NG7 2UH, UKDivision of Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, Faculty of Medicine and Health Sciences, University of Nottingham, E Floor, West Block, Queen’s Medical Centre, Derby Rd, Nottingham NG7 2UH, UKResearch & Development Department, Lincoln Breast Unit, Lincoln County Hospital, Greetwell Road, Lincoln LN2 5QY, UKDepartment of Pathology, PathLinks, Lincoln County Hospital, Greetwell Road, Lincoln LN2 5QY, UKAcademic Department of Pathology, Faculty of Medicine and Health Sciences, University of Nottingham, A Floor, West Block, Queens Medical Centre, Derby Road, Nottingham NG7 2UH, UKDivision of Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, Faculty of Medicine and Health Sciences, University of Nottingham, E Floor, West Block, Queen’s Medical Centre, Derby Rd, Nottingham NG7 2UH, UKThe tumour microenvironment consists of malignant cells, stroma, and immune cells. Prominent tumour-infiltrating lymphocytes (TILs) in breast cancer are associated with a good prognosis and are predictors of a pathological complete response (pCR) with neoadjuvant chemotherapy (NAC). The contribution of different T effector/regulatory cells and cytokines to tumour cell death with NAC requires further characterisation and was investigated in this study. Breast tumours from 33 women with large and locally advanced breast cancers undergoing NAC were immunohistochemically (intratumoural, stromal) assessed for T cell subsets and cytokine expression using labelled antibodies, employing established semiquantitative methods. Prominent levels of TILs and CD4+, CD8+, and CTLA-4+ (stromal) T cells and CD8+ : FOXP3+ ratios were associated with a significant pCR; no association was seen with FOXP3+, CTLA-4+ (intratumoural), and PD-1+ T cells. NAC significantly reduced CD4+, FOXP3+, CTLA-4+ (stromal) (concurrently blood FOXP3+, CTLA-4+ Tregs), and PD-1+ T cells; no reduction was seen with CD8+ and CTLA-4+ (intratumoural) T cells. High post-NAC tumour levels of FOXP3+ T cells, IL-10, and IL-17 were associated with a failed pCR. Our study has characterised further the contribution of T effector/regulatory cells and cytokines to tumour cell death with NAC.http://dx.doi.org/10.1155/2016/4757405 |
| spellingShingle | Viriya Kaewkangsadan Chandan Verma Jennifer M. Eremin Gerard Cowley Mohammed Ilyas Oleg Eremin Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer Journal of Immunology Research |
| title | Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer |
| title_full | Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer |
| title_fullStr | Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer |
| title_full_unstemmed | Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer |
| title_short | Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer |
| title_sort | crucial contributions by t lymphocytes effector regulatory and checkpoint inhibitor and cytokines th1 th2 and th17 to a pathological complete response induced by neoadjuvant chemotherapy in women with breast cancer |
| url | http://dx.doi.org/10.1155/2016/4757405 |
| work_keys_str_mv | AT viriyakaewkangsadan crucialcontributionsbytlymphocyteseffectorregulatoryandcheckpointinhibitorandcytokinesth1th2andth17toapathologicalcompleteresponseinducedbyneoadjuvantchemotherapyinwomenwithbreastcancer AT chandanverma crucialcontributionsbytlymphocyteseffectorregulatoryandcheckpointinhibitorandcytokinesth1th2andth17toapathologicalcompleteresponseinducedbyneoadjuvantchemotherapyinwomenwithbreastcancer AT jennifermeremin crucialcontributionsbytlymphocyteseffectorregulatoryandcheckpointinhibitorandcytokinesth1th2andth17toapathologicalcompleteresponseinducedbyneoadjuvantchemotherapyinwomenwithbreastcancer AT gerardcowley crucialcontributionsbytlymphocyteseffectorregulatoryandcheckpointinhibitorandcytokinesth1th2andth17toapathologicalcompleteresponseinducedbyneoadjuvantchemotherapyinwomenwithbreastcancer AT mohammedilyas crucialcontributionsbytlymphocyteseffectorregulatoryandcheckpointinhibitorandcytokinesth1th2andth17toapathologicalcompleteresponseinducedbyneoadjuvantchemotherapyinwomenwithbreastcancer AT olegeremin crucialcontributionsbytlymphocyteseffectorregulatoryandcheckpointinhibitorandcytokinesth1th2andth17toapathologicalcompleteresponseinducedbyneoadjuvantchemotherapyinwomenwithbreastcancer |